Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound en…
Drug Manufacturers - Specialty & Generic
US, North Billerica [HQ]
LNTH/Financial Reporting
Income Statements
13 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 356.00 | 288.00 | 283.00 | 301.00 | 293.00 | 301.00 | 331.00 | 343.00 | 347.00 | 339.00 | 425.00 | 935.00 | 1,296.00 | |
|
EPS
|
-7.61 | -2.36 | -3.40 | -0.20 | -0.60 | 0.84 | 3.31 | 1.06 | 0.81 | -0.25 | -1.06 | 0.41 | 4.79 | |
| Diluted in mil. | -7.61 | -2.32 | -3.34 | -0.20 | -0.60 | 0.82 | 3.17 | 1.03 | 0.79 | -0.25 | -1.06 | 0.40 | 4.65 | |
|
Profit
|
95.00 | 75.00 | 77.00 | 125.00 | 135.00 | 137.00 | 162.00 | 174.00 | 174.00 | 138.00 | 187.00 | 581.00 | 709.00 | |
| Gross Margin | 26.72 | 26.10 | 27.27 | 41.62 | 46.18 | 45.64 | 48.93 | 50.93 | 50.33 | 40.88 | 44.14 | 62.21 | 54.73 | |
| Pre Tax | -53.00 | -42.00 | -60.00 | -2.00 | -11.00 | 28.00 | 39.00 | 49.00 | 28.00 | -11.00 | -75.00 | 26.00 | 410.00 | |
| Profit Margin | -14.92 | -14.77 | -21.34 | -0.78 | -4.01 | 9.37 | 11.96 | 14.43 | 8.24 | -3.38 | -17.65 | 2.86 | 31.70 | |
| ETR | -158.12 | 1.30 | -1.67 | -50.51 | -25.20 | 5.41 | -211.27 | 18.22 | -10.62 | -17.37 | 5.01 | -5.05 | 20.51 | |
| Net | -137.00 | -42.00 | -61.00 | -3.00 | -14.00 | 26.00 | 123.00 | 40.00 | 31.00 | -13.00 | -71.00 | 28.00 | 326.00 | |
| Profit Margin | -38.52 | -14.58 | -21.70 | -1.18 | -5.02 | 8.87 | 37.23 | 11.80 | 9.12 | -3.97 | -16.76 | 3.00 | 25.20 | |
| EBITDA | 16.00 | 27.00 | 13.00 | 57.00 | 42.00 | 50.00 | 60.00 | 66.00 | 45.00 | -2.00 | -83.00 | 34.00 | 444.00 | |
| EBITDA Margin | 4.50 | 9.40 | 4.63 | 19.13 | 14.47 | 16.70 | 18.25 | 19.50 | 13.08 | -0.59 | -19.62 | 3.69 | 34.26 | |
| Operating Income | -17.00 | - - | -18.00 | 39.00 | 42.00 | 56.00 | 51.00 | 64.00 | 32.00 | -4.00 | -76.00 | -13.00 | 364.00 | |
| Operating Margin | -4.85 | -0.26 | -6.66 | 13.07 | 14.49 | 18.75 | 15.65 | 18.78 | 9.23 | -1.24 | -17.89 | -1.44 | 28.13 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 2.00 | 19.00 | |
| Loss | -373.00 | -323.00 | -305.00 | -262.00 | -250.00 | -251.00 | -279.00 | -278.00 | -295.00 | -343.00 | -501.00 | -898.00 | -931.00 | |
| Cost of Revenue | -261.00 | -212.00 | -206.00 | -176.00 | -157.00 | -164.00 | -169.00 | -168.00 | -172.00 | -200.00 | -237.00 | -353.00 | -586.00 | |
|
Operating Expenses
|
-112.00 | -110.00 | -98.00 | -86.00 | -92.00 | -87.00 | -110.00 | -110.00 | -123.00 | -142.00 | -263.00 | -545.00 | -344.00 | |
| R&D | -40.00 | -40.00 | -30.00 | -13.00 | -14.00 | -12.00 | -18.00 | -17.00 | -20.00 | -32.00 | -44.00 | -311.00 | -77.00 | |
| G&A | -32.00 | -32.00 | -33.00 | -37.00 | -43.00 | -38.00 | -49.00 | -50.00 | -61.00 | -69.00 | -150.00 | -133.00 | -125.00 | |
| SG&A | -71.00 | -69.00 | -68.00 | -72.00 | -78.00 | -75.00 | -92.00 | -93.00 | -103.00 | -110.00 | -218.00 | -233.00 | -267.00 | |
| S&M | -38.00 | -37.00 | -35.00 | -35.00 | -34.00 | -36.00 | -42.00 | -43.00 | -41.00 | -40.00 | -68.00 | -100.00 | -141.00 | |
| Depreciation and Amortization | -32.00 | -27.00 | -25.00 | -18.00 | -19.00 | -18.00 | -19.00 | -13.00 | -13.00 | -24.00 | -42.00 | -47.00 | -60.00 | |
| Interest Expenses | -37.00 | -42.00 | -42.00 | -42.00 | -38.00 | -26.00 | -18.00 | -17.00 | -13.00 | -9.00 | -7.00 | -7.00 | -20.00 | |
| Other Expenses | -1.00 | -34.00 | -3.00 | - - | -15.00 | -4.00 | -6.00 | -2.00 | -3.00 | -7.00 | -1.00 | -40.00 | -46.00 | |
|
WA Shares Outstanding
|
18.00 | 17.00 | 18.00 | 17.00 | 24.00 | 32.00 | 37.00 | 38.00 | 38.00 | 54.00 | 67.00 | 68.00 | 68.00 | |
| Diluted | 18.00 | 18.00 | 18.00 | 18.00 | 24.00 | 32.00 | 38.00 | 39.00 | 40.00 | 54.00 | 67.00 | 70.00 | 70.00 |